In this video series exploring biotech innovation, Christian Cobaugh, founder and CEO of Vernal, discusses the critical role of analytical services in the success of mRNA and lipid nanoparticles (LNPs) therapeutics. Interviewed by Kristyn Cook, Executive Director of Marketing, he emphasizes the importance of specialized analytical services in maintaining quality, addressing market needs, and meeting regulatory requirements. Cobaugh highlights Vernal’s unique service offerings, collaborative client approach, and the ultimate impact on patient health outcomes, while also providing valuable advice for emerging biotech companies. Listen now!
